The purpose of the study is to verify and validate the parameters collected from mobile devices via the app named "Comestai" and from reference devices. The assessments considered to define comorbidities are included.. Specifically, collection of vital parameters (Blood Pressure, Heart Rate, Respiratory Rate, Oxygen Saturation) through the "Comestai" Application via mobile phones (using photoplethysmographic method) and reference devices such as Withings-Blood Pressure Monitor Connect® (for Blood Pressure), Polar Verity Sense® (for Heart Rate), Masimo-finger sensor® (for Oxygen Saturation, Respiratory Rate), comparing and confirming them. Consent will be sought for the viewing and collection of blood test results that are normally included in evaluations for subjects with overweight and/or obesity and/or diabetes.
Estimated time required for each measurement recording: 10-15 minutes per subject
Total number of subjects: 3000
Eligibility
Sex
ALL
Min age
16 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
Prior to enrollment in this study, subjects must meet all the following inclusion criteria:
1. Subject must have the ability to understand and provide written informed consent.
2. Male or Female subject ≥16 and ≤65 of age.
3. Subject must be willing and able to comply with study procedures.
Exclusion Criteria:
Subjects will be excluded from the study if any of the following conditions are present:
1. Subject with compromised circulation, injury, or physical malformation of fingers, hands, ears or forehead/skull or other sensor Region of Interest (ROI) which would limit the ability to test ROI needed for the study.
2. Subject has a tattoo in the optical path which would limit the ability to test ROI needed for the study.
3. Subjects with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, respiration monitor electrodes or other medical sensors used for measuring vital signs.
4. Subject with a medical condition which in the opinion of the investigator, does not allow performing the study assessments.
5. Subject unfit to participate in the study to the judgment of the investigator.
In addition to the Inclusion/Exclusion criteria, the 70% of target population should include adult subjects with at least one of the following:
* Pre-diabetes or diabetes HbA1C 5.7-13%
* \>30% of subjects with HbA1C 5.7-6.4%
* \>30% of subjects with HbA1C \>6.4%
* Hypertension with systolic measurements above 130 mmHg
* \>40% of subjects with systolic BP \>130 mmHg
* \>20% of subjects with systolic BP \>160 mmHg
* Total cholesterol: \>40% of subjects with \>200 mg/dl and/or LDL above 130 mg/dl
* Atrial fibrillation 1%
* Smokers \~ 20-30% of all subjects in the study
Note: the same subject can have more than one of the above medical conditions. It is preferred that subjects will be treatment- naive for the medical condition they suffer from or are not under treatment at the time of participation (e.g. a subject who suffers from hypertension has not started his treatment to lower his blood pressure).
Primary outcome measure(s)
Data Collection Storage and Processing-Pulse rate — 15 minutes for data collection Collect, verify and validate Pulse rate (beats per minute) in data using the Comestai application and reference devices.
Pulse rate data obtained using the Comestai application and reference data will be stored on Comestai's secured cloud without any subject identifiable information and will only be recognized using the subject identification number provided during screening. The raw data of subjects' vital signs will be locked, encrypted, and can be read only by Study center team.
The measurement method utilized by the app is Remote Photoplethysmography (rPPG).
No medical decisions will be made based on the data obtained using the Comestai application, the reference devices, and the pre-scheduled blood sample results.
Data Collection Storage and Processing-Oxygen saturation — 15 minutes for data collection Collect, verify and validate Oxygen saturation (percentage) in data using the Comestai application and reference devices.
Oxygen saturation data obtained using the Comestai application and reference data will be stored on Comestai's secured cloud without any subject identifiable information and will only be recognized using the subject identification number provided during screening. The raw data of subjects' vital signs will be locked, encrypted, and can be read only by Study center team.
The measurement method utilized by the app is Remote Photoplethysmography (rPPG).
No medical decisions will be made based on the data obtained using the Comestai application, the reference devices, and the pre-scheduled blood sample results.
Data Collection Storage and Processing-Respiratory rate — 15 minutes for data collection Collect, verify and validate Respiratory rate (breaths per minute) in data using the Comestai application and reference devices.
Respiratory rate data obtained using the Comestai application and reference data will be stored on Comestai's secured cloud without any subject identifiable information and will only be recognized using the subject identification number provided during screening. The raw data of subjects' vital signs will be locked, encrypted, and can be read only by Study center team.
The measurement method utilized by the app is Remote Photoplethysmography (rPPG).
No medical decisions will be made based on the data obtained using the Comestai application, the reference devices, and the pre-scheduled blood sample results.
Data Collection Storage and Processing-Blood pressure — 15 minutes for data collection Collect, verify and validate Blood pressure (mmHg) in data using the Comestai application and reference devices.
Blood pressure data obtained using the Comestai application and reference data will be stored on Comestai's secured cloud without any subject identifiable information and will only be recognized using the subject identification number provided during screening. The raw data of subjects' vital signs will be locked, encrypted, and can be read only by Study center team.
The measurement method utilized by the app is Remote Photoplethysmography (rPPG).
No medical decisions will be made based on the data obtained using the Comestai application, the reference devices, and the pre-scheduled blood sample results.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
